IP Library Granted Patent US 11,371,992
Granted Patent B2
US 11,371,992 · App. 16/589,420 · Granted Jun 28, 2022

Solid phase immunoassay apparatus and method for rapid detection of bacteria

Inventors: Bentolhoda Heli (Montreal, CA); Abdellah Ajji (Mont-Royal, CA)
Assignee: POLYVALOR, LIMITED PARTNERSHIP
G01N33/56911G01N21/6428G01N33/54306G01N33/582G01N33/588B82Y15/00G01N33/54346G01N2021/6441
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,371,992
App. No.
16/589,420
Granted
Jun 28, 2022
Kind
B2
Abstract

An assay device is provided for use in determining the presence of a target analyte in a sample. The assay device comprises a solid platform comprising a fibrous mat, the solid platform impregnated with a first FRET chromophore. An antibody-FRET chromophore conjugate is immobilized on a surface of the solid platform, wherein the antibody-FRET chromophore conjugate comprises an antibody affixed to a second FRET chromophore. The first FRET chromophore and the second FRET chromophore are selected to provide an energy transfer from one to another when located within a Förster distance with respect to each other, thereby forming a FRET donor-acceptor chromophore pair. In a further aspect, a method of detecting a target analyte in a sample is provided. In yet a further aspect, packaging sheet materials and packaging articles employing the assay device under certain conditions are provided.

Claims (39)

1. An assay device for use in determining the presence of a target analyte in a sample, the assay device comprising:

a solid platform comprising a fibrous mat, the solid platform impregnated with a first FRET chromophore, wherein the first FRET chromophore is not attached to an antibody and further wherein the first FRET chromophore is immobilized within the fibrous mat; and

an antibody-FRET chromophore conjugate immobilized on a surface of the solid platform, the antibody-FRET chromophore conjugate comprising an antibody affixed to a second FRET chromophore;

wherein the first FRET chromophore and the second FRET chromophore are selected to provide an energy transfer from one to another when located within a Förster distance with respect to each other, thereby forming a FRET donor-acceptor FRET chromophore pair; and

wherein the antibody affixed to the second FRET chromophore is configured to position the second FRET chromophore in relation to the first FRET chromophore to perform the energy transfer as a result of a conformational change in the antibody upon capture of a microbial contaminant by the antibody.

2. The assay device of claim 1 , wherein the fibrous mat comprises one or both of bacterial cellulose and carboxylated bacterial cellulose.

3. The assay device of claim 1 , wherein the first FRET chromophore is a FRET acceptor.

4. The assay device of claim 3 , wherein the first FRET chromophore comprises nanoparticles selected from the group consisting of noble metal nanoparticles, gold nanoparticles, and silver nanoparticles.

5. The assay device of claim 4 , wherein the first FRET chromophore comprises gold nanoparticles.

6. The assay device of claim 5 , wherein the gold nanoparticles are formed within the fibrous mat in situ.

7. The assay device of claim 1 , wherein the antibody-FRET chromophore conjugate is immobilized on the fibrous mat with a protein covalently bonded to the fibrous mat.

8. The assay device of claim 7 , wherein the protein is bound to an Fc region of the antibody.

9. The assay device of claim 7 , wherein the protein is selected from the group consisting of Protein A and Protein A/G.

10. The assay device of claim 1 , wherein the second FRET chromophore is a FRET donor.

11. The assay device of claim 10 , wherein the second FRET chromophore is selected from the group consisting of a quantum dot and a fluorescent dye.

12. The assay device of claim 1 , wherein the antibody is an antibody against a foodborne pathogen.

13. The assay device of claim 1 , wherein the antibody is an antibody against a foodborne pathogen selected from the group consisting of E. coli, Salmonella, Listeria , and Campylobacter.

14. A method of detecting a target analyte in a sample, the method comprising:

combining the sample with an assay device, the assay device comprising a solid platform comprising a fibrous mat, the solid platform impregnated with a first FRET chromophore, wherein the first FRET chromophore is not attached to an antibody and further wherein the first FRET chromophore is immobilized within the fibrous mat, and an antibody-FRET chromophore conjugate immobilized on a surface of the solid platform, the antibody-FRET chromophore conjugate comprising an antibody affixed to a second FRET chromophore, wherein the first FRET chromophore and the second FRET chromophore are selected to provide an energy transfer from one to another when located within a Förster distance with respect to each other, thereby forming a FRET donor-acceptor chromophore pair, and wherein the antibody affixed to the second FRET chromophore is configured to position the second FRET chromophore in relation to the first FRET chromophore to perform the energy transfer as a result of a conformational change in the antibody upon capture of a microbial contaminant by the antibody; and

measuring at least one FRET signal generated by the first FRET chromophore and/or second FRET chromophores to detect the target analyte in the sample.

15. The method of claim 14 , wherein the fibrous mat comprises one or both of bacterial cellulose and carboxylated bacterial cellulose.

16. The method of claim 14 , wherein the first FRET chromophore is a FRET acceptor.

17. The method of claim 16 , wherein the first FRET chromophore comprises nanoparticles selected from the group consisting of noble metal nanoparticles, gold nanoparticles, and silver nanoparticles.

18. The method of claim 17 , wherein the first FRET chromophore comprises gold nanoparticles.

19. The method of claim 18 , wherein the gold nanoparticles are formed within the fibrous mat in situ.

20. The method of claim 14 , wherein the antibody-FRET chromophore conjugate is immobilized on the fibrous mat with a protein covalently bonded to the fibrous mat.

21. The method of claim 20 , wherein the protein is bound to an Fc region of the antibody.

22. The method of claim 21 , wherein the protein is selected from the group consisting of Protein A and Protein A/G.

23. The method of claim 14 , wherein the second FRET chromophore is a FRET donor.

24. The method of claim 23 , wherein the second FRET chromophore is selected from the group consisting of a quantum dot and a fluorescent dye.

25. The method of claim 14 , wherein the antibody is an antibody against a foodborne pathogen.

26. The method of claim 14 , wherein the antibody is an antibody against a foodborne pathogen selected from the group consisting of E. coli, Salmonella, Listeria , and Campylobacter.

27. A packaging material for detection of microbial contamination in a sample, the packaging material comprising a packaging sheet material and an assay device, the assay device comprising:

a solid platform comprising a fibrous mat, the solid platform impregnated with a first FRET chromophore, wherein the first FRET chromophore is not attached to an antibody and further wherein the first FRET chromophore is immobilized within the fibrous mat; and

an antibody-FRET chromophore conjugate immobilized on a surface of the solid platform, the antibody-FRET chromophore conjugate comprising an antibody affixed to a second FRET chromophore;

wherein the first FRET chromophore and the second FRET chromophore are selected to provide an energy transfer from one to another when located within a Förster distance with respect to each other, thereby forming a FRET donor-acceptor chromophore pair, wherein the sample contacts the assay device, and wherein the energy transfer is configured to trigger an optically detectable change in signal in the presence of a microbial contaminant; and

wherein the antibody affixed to the second FRET chromophore is configured to position the second FRET chromophore in relation to the first FRET chromophore to perform the energy transfer as a result of a conformational change in the antibody upon capture of a microbial contaminant by the antibody.

28. The packaging material of claim 27 , wherein the sample is a food product.

29. The packaging material of claim 27 , wherein the packaging sheet material is a polymer film.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Mar 6, 2026
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (AS SUCCESSOR IN INTEREST TO U.S. BANK NATIONAL ASSOCIATION), AS COLLATERAL AGENT
To: AMPAC FLEXIBLES, LLC; AMPAC FLEXICON, LLC; AMPAC HOLDCO, INC.; AMPAC HOLDINGS, LLC; AMPAC MOBILE HOLDINGS, LLC; AMPAC PACKAGING, LLC; AMPAC PAPER, LLC; AMPAC PLASTICS, LLC; BONITA PACKAGING PRODUCTS, INC.; CEI HOLDINGS, LLC; COATING EXCELLENCE INTERNATIONAL, LLC; GATEWAY PACKAGING COMPANY LLC; JEN-COAT, INC.; MOHAWK NORTHERN PLASTICS, LLC; POLYFIRST PACKAGING, INC.; PROAMPAC HOLDINGS INC.; PROAMPAC ORLANDO INC.; PROAMPAC PG BORROWER LLC; PROAMPAC PG INTERMEDIATE LLC; PROAMPAC REAL ESTATE HOLDINGS LLC; PROAMPAC ROCHESTER LLC; PROLAMINA CORPORATION; PROLAMINA MIDWEST CORPORATION; TRINITY PACKAGING CORPORATION; TULSACK LLC; TWISTED PAPER PRODUCTS, INC.; VITEX PACKAGING, INC.; PAC WORLDWIDE CORPORATION
Reel/Frame 075021/0794 →
SECURITY INTEREST Recorded Jan 27, 2021
From: AMPAC FLEXIBLES, LLC; AMPAC FLEXICON, LLC; AMPAC HOLDCO, INC.; AMPAC HOLDINGS, LLC; AMPAC MOBILE HOLDINGS, LLC; AMPAC PACKAGING, LLC; AMPAC PAPER, LLC; AMPAC PLASTICS, LLC; BONITA PACKAGING PRODUCTS, INC.; CEI HOLDINGS, LLC; COATING EXCELLENCE INTERNATIONAL, LLC; GATEWAY PACKAGING COMPANY LLC; JEN-COAT, INC.; MOHAWK NORTHERN PLASTICS, LLC; POLYFIRST PACKAGING, INC.; PROAMPAC HOLDINGS INC.; PROAMPAC ORLANDO INC.; PROAMPAC PG BORROWER LLC; PROAMPAC PG INTERMEDIATE LLC; PROAMPAC REAL ESTATE HOLDINGS LLC; PROAMPAC ROCHESTER LLC; PROLAMINA CORPORATION; PROLAMINA MIDWEST CORPORATION; TRINITY PACKAGING CORPORATION; TULSACK LLC; TWISTED PAPER PRODUCTS, INC.; VITEX PACKAGING, INC.
To: U.S. BANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 055139/0731 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2020
From: CORPORATION DE L'ÉCOLE POLYTECHNIQUE DE MONTRÉAL
To: POLYVALOR, LIMITED PARTNERSHIP
Reel/Frame 053952/0285 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2020
From: HELI, BENTOLHODA; AJJI, ABDELLAH
To: CORPORATION DE L'ÉCOLE POLYTECHNIQUE DE MONTRÉAL
Reel/Frame 053932/0562 →
Continuity (2)
Provisional Application 62740063 · Oct 2, 2018
Related Publication 20200103404A1 · Apr 2, 2020